
November 28, 2017 - By Marguerite Chambers
 Lannett Comp (NYSE:LCI) had a decrease of 5.41% in short interest. LCI’s SI was 15.44M shares in November as released by FINRA. Its down 5.41% from 16.32M shares previously. With 891,400 avg volume, 17

Among 8 analysts covering Taiwan Semiconductor Manufacturing (NYSE:TSM), 2 have Buy rating, 0 Sell and 6 Hold. Therefore 25% are positive. Taiwan Semiconductor Manufacturing has $26 highest and $14 lowest target. $21’s average target is -48.89% below currents $41.09 stock price. Taiwan Semiconductor Manufacturing had 12 analyst reports since August 24, 2015 according to SRatingsIntel. The stock of Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM) has “Outperform” rating given on Friday, December 11 by Credit Suisse. The firm has “Neutral” rating by Goldman Sachs given on Tuesday, June 28. Pacific Crest upgraded the stock to “Sector Weight” rating in Friday, October 14 report. The firm has “Hold” rating by HSBC given on Thursday, October 13. The rating was downgraded by Morgan Stanley on Monday, November 27 to “Equal-Weight”. The firm earned “Buy” rating on Tuesday, October 10 by J.P. Morgan. The stock has “Hold” rating by KeyBanc Capital Markets on Wednesday, September 6. HSBC downgraded the stock to “Hold” rating in Wednesday, June 21 report. The rating was upgraded by Susquehanna to “Neutral” on Tuesday, October 4.Analysts await Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM) to report earnings on January, 11. They expect $0.61 earnings per share, 0.00% or $0.00 from last year’s $0.61 per share. TSM’s profit will be $3.00 billion for 16.84 P/E if the $0.61 EPS becomes a reality. After $0.57 actual earnings per share reported by Taiwan Semiconductor Mfg. Co. Ltd. (ADR) for the previous quarter, Wall Street now forecasts 7.02% EPS growth. Taiwan Semiconductor Manufacturing Company Limited is a semiconductor foundry. The company has market cap of $201.88 billion. The Firm is engaged in the manufacturing, selling, packaging, testing and computer-aided design of integrated circuits and other semiconductor devices and the manufacturing of masks. It has a 18.19 P/E ratio. It operates through foundry segment.The stock decreased 4.42% or $1.9 during the last trading session, reaching $41.09. About shares traded. Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM) has risen 51.40% since November 28, 2016 and is uptrending. It has outperformed by 34.70% the S&P500.Investors sentiment decreased to 0.88 in 2017 Q2. Its down 0.75, from 1.63 in 2017Q1. It turned negative, as 25 investors sold Lannett Company, Inc. shares while 44 reduced holdings. 17 funds opened positions while 44 raised stakes. 32.05 million shares or 7.73% less from 34.74 million shares in 2017Q1 were reported. Principal Financial Gp owns 0% invested in Lannett Company, Inc. (NYSE:LCI) for 223,715 shares. Alps Advsrs stated it has 0.01% of its portfolio in Lannett Company, Inc. (NYSE:LCI). Focused Wealth Management holds 0.01% or 1,850 shares in its portfolio. Royal National Bank Of Canada accumulated 0% or 18,374 shares. Barclays Public Limited Company holds 0% or 12,065 shares in its portfolio. Moreover, Meeder Asset Mngmt has 0% invested in Lannett Company, Inc. (NYSE:LCI) for 151 shares. The Oklahoma-based Pinnacle Ltd has invested 0% in Lannett Company, Inc. (NYSE:LCI). State Of Alaska Department Of Revenue has invested 0.01% in Lannett Company, Inc. (NYSE:LCI). New Jersey-based Prudential has invested 0% in Lannett Company, Inc. (NYSE:LCI). White Pine Limited Com reported 24,275 shares or 0.2% of all its holdings. Oz Mgmt Lp holds 45,000 shares. Gsa Capital Ptnrs Llp owns 27,166 shares. Macquarie Group Limited, Australia-based fund reported 44,200 shares. 3.85 million are held by Blackrock Inc. State Of Wisconsin Invest Board has invested 0% in Lannett Company, Inc. (NYSE:LCI).Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The company has market cap of $969.94 million. The Firm makes and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. It has a 23.01 P/E ratio. As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.Among 10 analysts covering Lannett (NYSE:LCI), 6 have Buy rating, 1 Sell and 3 Hold. Therefore 60% are positive. Lannett had 26 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating by Oppenheimer given on Thursday, June 8. The firm has “Buy” rating given on Friday, March 11 by Roth Capital. Zacks upgraded Lannett Company, Inc. (NYSE:LCI) rating on Monday, September 7. Zacks has “Strong-Buy” rating and $63 target. The firm has “Buy” rating given on Tuesday, August 22 by Roth Capital. The company was upgraded on Thursday, February 4 by Craig Hallum. The firm earned “Outperform” rating on Wednesday, August 24 by Raymond James. Oppenheimer maintained the stock with “Hold” rating in Wednesday, August 23 report. Canaccord Genuity downgraded it to “Sell” rating and $18 target in Thursday, March 24 report. Deutsche Bank maintained the shares of LCI in report on Monday, August 14 with “Hold” rating. The firm has “Buy” rating by Craig Hallum given on Thursday, August 27.By Marguerite ChambersEchostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.